SHBN Webinar – Safer Handling of Hazardous Medicinal Products: Evidence, Practice and Policy Change

This session will bring together research and policy perspectives to explore the current evidence base, the practical realities faced by healthcare professionals, and the policy considerations shaping future improvements in HMP safety.

The webinar will feature presentations from:

-Dr Karen Campbell, Immediate Past President, UK Oncology Nursing Society (UKONS) Louise Church, Head of Health, Safety and Wellbeing in Employment Relations, Royal College of Nursing (RCN)

-Dr Campbell will present findings from her latest research, offering insight into how occupational exposure to HMPs occurs in practice and the symptoms reported by healthcare workers. Louise Church will outline the RCN’s recent position paper, highlighting key risks, gaps in the current regulatory framework, and recommendations to strengthen protections for staff.

Drawing on both research and frontline experience, the session will examine patterns of exposure, associated health risks, and the challenges of managing these risks within existing frameworks such as COSHH. It will also explore practical approaches to risk reduction, including engineering controls, environmental monitoring, training, and governance, alongside the need for clearer definitions and more consistent implementation.

This webinar will be of interest to healthcare professionals, policymakers, safety specialists, and all those involved in the handling of hazardous medicinal products.

Register here: https://us06web.zoom.us/meeting/register/U2RKjwtORMmgO6x5zsy0jQ

This webinar is delivered a part of the UK HMP Safety campaign, find out more here: https://shbn.org.uk/hmp-safety/

Latest News

By NHS Infusions and Special Medicines Programme on 4th September 2026

Expressions of interest for Expert Panel Sub Group to support the approval and implementation of Standardised Product Specifications

Expressions of interest for Expert Panel Sub Group to support the approval and implementation of Standardised Product Specifications The Infusions and Special Medicines Programme is inviting expressions of interest for…

Read article
By BOPA on 31st August 2026

🌟 BOPA Advanced Pharmacist Study Day – Elevate Your Practice, Shape Your Career

Are you an oncology or haematology pharmacist with around five or more years of experience — whether Band 7 or Band 8 — and ready to take the next step…

Read article
By BOPA Executive Committee on 31st August 2026

BOPA 2026 Executive Committee Election – One week left to cast your vote

One week left to cast your vote for the BOPA Executive Committee Election. Have your say at BOPA’s future.   In 2026 we received 9 nominations for 6 positions. -Standard…

Read article
By BOPA Executive Committee on 27th August 2026

UK multidisciplinary Consensus Document – Safe Management of Hazardous Medicinal Products in UK Healthcare Settings

We are pleased to jointly publish the new UK multidisciplinary consensus document, Safe Management of Hazardous Medicinal Products in UK Healthcare Settings. Hazardous medicinal products (HMPs) are used across a…

Read article